Useful Advices - Business

The web 2.0 movement is certainly mainstream at this point. A quick look

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

at the VC investment data shows that this is no longer a fringe movemen

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

t. Having lived through the dot-com experience, running an Internet star

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

t-up at the time (which made it through to this day), I have a few obser

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

vations about this latest craze.

The number one objection I have to Web

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

2.0 is the lack of definition for the term itself. Whenever there is a

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

"buzz" about something people can't quite define, I tend to believe it's

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

not real. Or at least, the idea is still in a formation stage. We heard

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

this in the 90's, "the Internet is changing the very fundamentals of bus

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

iness." But when you asked people how, they couldn't really answer. Thei

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

r only reply was: "You'll see." Well, we certainly saw. Business is busi

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ness, and always will be. There needs to be a return of x percent in y y

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ears, or investments generally are not offered.

Will Web 2.0 bring new

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

and interesting ways to make money? I think so. I'm quite intrigued by t

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

e possibilities. But my money is on the sidelines at this point. I think

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

that the money that's out there now is somewhat foolish. Maybe foolish

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

is a little harsh. It's the early-adopter money. It's a typical investme

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

nt pattern, really. The early money will largely be lost, but is necessa

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ry to help define how to use a new technology. The 1% who make it throug

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

h the first few years will see incredible returns. The other 99%, well..

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.usefuladvices.org.ua/article/46536/usefuladvices-Web-20-Feels-Like-DotCom-All-Over-Again.html">Web 2.0 Feels Like Dot-Com All Over Again</a>

BB link (for phorums):
[url=http://www.usefuladvices.org.ua/article/46536/usefuladvices-Web-20-Feels-Like-DotCom-All-Over-Again.html]Web 2.0 Feels Like Dot-Com All Over Again[/url]

Have you tried doing business with a major corporation lately only to be left angry and in total frustration? The levels of incompetence seems to be rapidly growing by the day. Common sense has left us forever and has been replaced with the ever-growing ignorance, emotions and incompetency of these screw-balls that are running the asylum.

As a consumer we often shop at our favorite stores and go to our favorite restaurants. Many times we make a choice solely based on the customer service we get and other times it is a combination of customer service and product. Nevertheless, the customer service aspect of it all is paramount and what keeps us coming back.

If your business relies on direct marketing campaigns and uses such companies as Money Mailer to send out coupons you may find yourself in a world of hurt during times of catastrophic hurricanes, which hit nearby regions.

Tags

Links

Useful Advices - Web 2.0 Feels Like Dot-Com All Over Again

Related Articles: